Skip to content

Prevention of thunderstorm asthma

Evaluation of the effect of inhaled corticosteroid in the prevention of thunderstorm asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016102520828N2
Enrollment
54
Registered
2017-01-02
Start date
2016-10-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thunderstorm asthma. Asthma

Interventions

Intervention 1: inhaled budesonide, 400 microgram daily for three months. Intervention 2: inhaled placebo,400 microgram daily for three months.
Treatment - Drugs
Placebo
inhaled budesonide, 400 microgram daily for three months
inhaled placebo,400 microgram daily for three months

Sponsors

Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria includes persons with the history of TS asthma. Exclusion criteria includes the persons with higher than 60 years and lower than 14 years old; use asthma maintenance drugs at the beginning of study; having asthma symptoms at the beginning of study; having chronic asthma at the start of study; FEV1 less than predicted eighty percent; appearing the asthma symptoms during the study so that patient needs maintenance treatment; symptoms of acute coronary syndrome; pregnant women; disability to do spirometry with high quality; Contraindications to perform spirometry; asking patients to get out of the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
FEV1. Timepoint: After three months. Method of measurement: spirometry.

Secondary

MeasureTime frame
Aasthma exacerbation measurement. Timepoint: After three months. Method of measurement: Fill in standard asthma excerbation questionaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSabere Shaheideari

Ahvaz Jundishapur Uuniversity of Medical Sciences

sabere.sabor@yahoo.com+98 61 3221 5574

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026